{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:47:59Z","timestamp":1750308479436,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":24,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"funder":[{"name":"Hubei Provincial Key Research and Development Plan,the Innovation and Entrepreneurship Fund for Graduate of Wuhan University of Science and Technology","award":["2020BCB048, 202110488030X"],"award-info":[{"award-number":["2020BCB048, 202110488030X"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,27]]},"DOI":"10.1145\/3543377.3543395","type":"proceedings-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T16:13:52Z","timestamp":1659975232000},"page":"120-124","source":"Crossref","is-referenced-by-count":0,"title":["Effect of PSPH on Angiogenesis and Migration of Hepatocellular Carcinoma Cells"],"prefix":"10.1145","author":[{"given":"Hang","family":"Min","sequence":"first","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Duo","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Fujian","family":"Wan","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Shijie","family":"Ding","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Jingjiao","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Health, Wuhan University of Science and Technology, China"}]}],"member":"320","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"e_1_3_2_1_1_1","first-page":"7","volume":"201","author":"Siegel R.L.","unstructured":"Siegel , R.L. , K.D. Miller , and A. Jemal , Cancer statistics, 2018. CA Cancer J Clin , 201 8. 68(1): p. 7 - 30 . Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7-30.","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_2_1_2_1","first-page":"5","volume":"201","author":"Siegel R.L.","unstructured":"Siegel , R.L. , K.D. Miller , and A. Jemal , Cancer statistics, 2015. CA Cancer J Clin , 201 5. 65(1): p. 5 - 29 . Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2015. CA Cancer J Clin, 2015. 65(1): p. 5-29.","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_2_1_3_1","first-page":"87","volume":"201","author":"Torre L.A.","unstructured":"Torre , L.A. , , Global cancer statistics, 2012. CA Cancer J Clin , 201 5. 65(2): p. 87 - 108 . Torre, L.A., , Global cancer statistics, 2012. CA Cancer J Clin, 2015. 65(2): p. 87-108.","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_2_1_4_1","first-page":"91","volume":"200","author":"Yuen M.F.","unstructured":"Yuen , M.F. and C.L. Lai , Serological markers of liver cancer. Best Pract Res Clin Gastroenterol , 200 5. 19(1): p. 91 - 99 . Yuen, M.F. and C.L. Lai, Serological markers of liver cancer. Best Pract Res Clin Gastroenterol, 2005. 19(1): p. 91-9.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"e_1_3_2_1_5_1","first-page":"698","volume":"201","author":"Schwabe R.F.","unstructured":"Schwabe , R.F. and T.C. Wang , Targeting liver cancer: first steps toward a miRacle? Cancer Cell , 201 1. 20(6): p. 698 - 699 . Schwabe, R.F. and T.C. Wang, Targeting liver cancer: first steps toward a miRacle? Cancer Cell, 2011. 20(6): p. 698-9.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_1_6_1","first-page":"11264","volume-title":"Proc Natl Acad Sci U S A","author":"Wang P.R.","year":"2012","unstructured":"Wang , P.R. , , Induction of hepatocellular carcinoma by in vivo gene targeting . Proc Natl Acad Sci U S A , 2012 . 109(28): p. 11264 - 11269 . Wang, P.R., , Induction of hepatocellular carcinoma by in vivo gene targeting. Proc Natl Acad Sci U S A, 2012. 109(28): p. 11264-9."},{"key":"e_1_3_2_1_7_1","first-page":"367","volume":"201","author":"Harding J.J.","unstructured":"Harding , J.J. , I. El Dika , and G.K. Abou-Alfa , Immunotherapy in hepatocellular carcinoma: Primed to make a difference? Cancer , 201 6. 122(3): p. 367 - 377 . Harding, J.J., I. El Dika, and G.K. Abou-Alfa, Immunotherapy in hepatocellular carcinoma: Primed to make a difference? Cancer, 2016. 122(3): p. 367-77.","journal-title":"Cancer"},{"key":"e_1_3_2_1_8_1","first-page":"292","volume":"201","author":"Zhu A.X.","unstructured":"Zhu , A.X. , , HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol , 201 1. 8(5): p. 292 - 301 . Zhu, A.X., , HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol, 2011. 8(5): p. 292-301.","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_3_2_1_9_1","first-page":"721","volume":"200","author":"Yang Z.F.","unstructured":"Yang , Z.F. and R.T. Poon , Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) , 200 8. 291(6): p. 721 - 734 . Yang, Z.F. and R.T. Poon, Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken), 2008. 291(6): p. 721-34.","journal-title":"Anat Rec (Hoboken)"},{"key":"e_1_3_2_1_10_1","first-page":"912","volume":"201","author":"Morse M.A.","unstructured":"Morse , M.A. , , The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res , 201 9. 25(3): p. 912 - 920 . Morse, M.A., , The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res, 2019. 25(3): p. 912-920.","journal-title":"Hepatocellular Carcinoma. Clin Cancer Res"},{"key":"e_1_3_2_1_11_1","volume-title":"Potential Molecular Targets and Drugs for Treatment of Hepatocellular Carcinoma. Journal of Cancer Science Therapy","author":"Mekuria A.N.","year":"2017","unstructured":"Mekuria , A.N. and A.D.J. Abdi , Potential Molecular Targets and Drugs for Treatment of Hepatocellular Carcinoma. Journal of Cancer Science Therapy , 2017 . 9(12). Mekuria, A.N. and A.D.J. Abdi, Potential Molecular Targets and Drugs for Treatment of Hepatocellular Carcinoma. Journal of Cancer Science Therapy, 2017. 9(12)."},{"key":"e_1_3_2_1_12_1","first-page":"768","volume":"200","author":"Arciero C.A.","unstructured":"Arciero , C.A. and E.R. Sigurdson , Liver-directed therapies for hepatocellular carcinoma. J Natl Compr Canc Netw , 200 6. 4(8): p. 768 - 774 . Arciero, C.A. and E.R. Sigurdson, Liver-directed therapies for hepatocellular carcinoma. J Natl Compr Canc Netw, 2006. 4(8): p. 768-74.","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_3_2_1_13_1","first-page":"23","volume":"201","author":"Amini A.","unstructured":"Amini , A. , , The critical role of vascular endothelial growth factor in tumor angiogenesis. Curr Cancer Drug Targets , 201 2. 12(1): p. 23 - 43 . Amini, A., , The critical role of vascular endothelial growth factor in tumor angiogenesis. Curr Cancer Drug Targets, 2012. 12(1): p. 23-43.","journal-title":"Curr Cancer Drug Targets"},{"key":"e_1_3_2_1_14_1","first-page":"1230","volume":"199","author":"Wang G.L.","unstructured":"Wang , G.L. and G.L. Semenza , Purification and characterization of hypoxia-inducible factor 1. J Biol Chem , 199 5. 270(3): p. 1230 - 1237 . Wang, G.L. and G.L. Semenza, Purification and characterization of hypoxia-inducible factor 1. J Biol Chem, 1995. 270(3): p. 1230-7.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_1_15_1","first-page":"1117","volume":"200","author":"Dempke W.C.M.","unstructured":"Dempke , W.C.M. and V. Heinemann , Resistance to EGF-R (erbB-1) and VEGF-R modulating agents. Eur J Cancer , 200 9. 45(7): p. 1117 - 1128 . Dempke, W.C.M. and V. Heinemann, Resistance to EGF-R (erbB-1) and VEGF-R modulating agents. Eur J Cancer, 2009. 45(7): p. 1117-1128.","journal-title":"Eur J Cancer"},{"key":"e_1_3_2_1_16_1","first-page":"114","volume-title":"Crit Care","author":"Giuliano J.S.","year":"2009","unstructured":"Giuliano , J.S. , Jr. and D.S. Wheeler , Excess circulating angiopoietin-2 levels in sepsis: harbinger of death in the intensive care unit ? Crit Care , 2009 . 13(1): p. 114 . Giuliano, J.S., Jr. and D.S. Wheeler, Excess circulating angiopoietin-2 levels in sepsis: harbinger of death in the intensive care unit? Crit Care, 2009. 13(1): p. 114."},{"key":"e_1_3_2_1_17_1","first-page":"305","volume":"202","author":"Zhang J.","unstructured":"Zhang , J. , , PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK\/mTOR\/ULK1 signaling pathway. Cell Biol Int , 202 1. 45(2): p. 305 - 319 . Zhang, J., , PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK\/mTOR\/ULK1 signaling pathway. Cell Biol Int, 2021. 45(2): p. 305-319.","journal-title":"Cell Biol Int"},{"key":"e_1_3_2_1_18_1","first-page":"2448","volume":"202","author":"Rawat V.","unstructured":"Rawat , V. , , PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene , 202 1. 40(13): p. 2448 - 2462 . Rawat, V., , PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene, 2021. 40(13): p. 2448-2462.","journal-title":"Oncogene"},{"key":"e_1_3_2_1_19_1","first-page":"183","volume":"201","author":"Liao L.","unstructured":"Liao , L. , , PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways. Int J Biol Sci , 201 9. 15(1): p. 183 - 194 . Liao, L., , PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways. Int J Biol Sci, 2019. 15(1): p. 183-194.","journal-title":"MAPK Signaling Pathways. Int J Biol Sci"},{"key":"e_1_3_2_1_20_1","volume-title":"Hypoxia-induced angiogenesis in human hepatocellular carcinoma. Journal of molecular medicine","author":"Kim K.","year":"2002","unstructured":"Kim , K. - R. , H.-E. Moon , and K. -W. Kim , Hypoxia-induced angiogenesis in human hepatocellular carcinoma. Journal of molecular medicine , 2002 . 80(11): p. 703-714. Kim, K.-R., H.-E. Moon, and K.-W. Kim, Hypoxia-induced angiogenesis in human hepatocellular carcinoma. Journal of molecular medicine, 2002. 80(11): p. 703-714."},{"key":"e_1_3_2_1_21_1","volume-title":"Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response. The British journal of radiology","author":"McKeown S.","year":"2014","unstructured":"McKeown , S. , Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response. The British journal of radiology , 2014 . 87(1035): p. 20130676. McKeown, S., Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response. The British journal of radiology, 2014. 87(1035): p. 20130676."},{"key":"e_1_3_2_1_22_1","first-page":"87","volume":"200","author":"Von Marschall Z.","unstructured":"Von Marschall , Z. , , Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut , 200 1. 48(1): p. 87 - 96 . Von Marschall, Z., , Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut, 2001. 48(1): p. 87-96.","journal-title":"Gut"},{"key":"e_1_3_2_1_23_1","volume-title":"Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma. Molecular pharmacology","author":"Xiong X.X.","year":"2017","unstructured":"Xiong , X.X. , , Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma. Molecular pharmacology , 2017 . 92(3): p. 246-255. Xiong, X.X., , Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma. Molecular pharmacology, 2017. 92(3): p. 246-255."},{"key":"e_1_3_2_1_24_1","volume-title":"Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer. Current cancer drug targets","author":"Agani F.","year":"2013","unstructured":"Agani , F. and B. -H. Jiang , Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer. Current cancer drug targets , 2013 . 13(3): p. 245-251. Agani, F. and B.-H. Jiang, Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer. Current cancer drug targets, 2013. 13(3): p. 245-251."}],"event":{"name":"ICBBT 2022: 2022 14th International Conference on Bioinformatics and Biomedical Technology","acronym":"ICBBT 2022","location":"Xi'an China"},"container-title":["2022 14th International Conference on Bioinformatics and Biomedical Technology"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3543377.3543395","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3543377.3543395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:43:11Z","timestamp":1750272191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3543377.3543395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":24,"alternative-id":["10.1145\/3543377.3543395","10.1145\/3543377"],"URL":"https:\/\/doi.org\/10.1145\/3543377.3543395","relation":{},"subject":[],"published":{"date-parts":[[2022,5,27]]}}}